Spots Global Cancer Trial Database for Apatinib for Resectable Colorectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Apatinib for Resectable Colorectal Cancer
Official Title: Apatinib With Postoperative Adjuvant Chemotherapy for Operable Colorectal Cancer
Study ID: NCT03228043
Study Description
Brief Summary: Objective: To compare the outcome of patients with colorectal cancer who treated with adjuvant therapy or Apatinib with adjuvant therapy postoperatively. Language: English.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Yunhong Tian, Nanchong, Sichuan, China
Contact Details
Name: Yunhong Tian
Affiliation: Nanchong Central Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
